@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ns1: <http://purl.org/vocab/frbr/core#> .
@prefix ns2: <http://purl.org/spar/pro/> .
@prefix ns3: <http://purl.org/spar/datacite/> .
@prefix ns4: <http://prismstandard.org/namespaces/basic/2.0/> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<> dcterms:license <https://creativecommons.org/publicdomain/zero/1.0/legalcode> .

<https://w3id.org/oc/meta/br/06402295666> a <http://purl.org/spar/fabio/Expression>,
        <http://purl.org/spar/fabio/JournalArticle> ;
    rdfs:label "br 06402295666" ;
    ns4:publicationDate "2020-10-24"^^xsd:date ;
    dcterms:title "Safety, Pharmacokinetics, And Efficacy Of Olorinab, A Peripherally Acting, Highly Selective, Full Agonist Of The Cannabinoid Receptor 2, In A Phase 2A Study Of Patients With Chronic Abdominal Pain Associated With Crohnâs Disease" ;
    ns3:hasIdentifier <https://w3id.org/oc/meta/id/06402189978>,
        <https://w3id.org/oc/meta/id/06490944682> ;
    ns2:isDocumentContextFor <https://w3id.org/oc/meta/ar/06409810719>,
        <https://w3id.org/oc/meta/ar/06409810720>,
        <https://w3id.org/oc/meta/ar/06409810721>,
        <https://w3id.org/oc/meta/ar/06409810722>,
        <https://w3id.org/oc/meta/ar/06409810723>,
        <https://w3id.org/oc/meta/ar/06409810724>,
        <https://w3id.org/oc/meta/ar/06409810725>,
        <https://w3id.org/oc/meta/ar/06409810726>,
        <https://w3id.org/oc/meta/ar/06409810727>,
        <https://w3id.org/oc/meta/ar/06409810728> ;
    ns1:partOf <https://w3id.org/oc/meta/br/06402295915>,
        <https://w3id.org/oc/meta/br/06804238003> .

